XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.8263
+0.0153 (1.89%)
At close: Sep 12, 2025, 4:00 PM EDT
0.8200
-0.0063 (-0.76%)
After-hours: Sep 12, 2025, 7:06 PM EDT
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of $4.29 million as of September 12, 2025. Its market cap has decreased by -13.35% in one year.
Market Cap
4.29M
Enterprise Value
3.32M
1-Year Change
-13.35%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from $25.10M to $4.29M, a decrease of -82.92%. That is a compound annual growth rate of -20.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 4.29M | 4.86% |
| Dec 30, 2024 | 4.09M | -6.85% |
| Dec 29, 2023 | 4.39M | -63.14% |
| Dec 30, 2022 | 11.91M | -53.60% |
| Dec 31, 2021 | 25.66M | 177.78% |
| Dec 31, 2020 | 9.24M | 19.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 676.91B |
| Johnson & Johnson | 429.41B |
| AbbVie | 388.13B |
| UnitedHealth Group | 321.37B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 232.89B |